跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
MALARONE TABLETS (250/100) atovaquone and proguanil hydrochloride tablet blister pack
Approved
STANDARD
MALARONE TABLETS (250/100) atovaquone and proguanil hydrochloride tablet blister pack
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
08608527c792df28
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
08608527c792df28
Product Name
MALARONE TABLETS (250/100) atovaquone and proguanil hydrochloride tablet blister pack
Artg Id
61100
Artg Name
MALARONE TABLETS (250/100) atovaquone and proguanil hydrochloride tablet blister pack
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
1998-05-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6c35c2d8d1bb2659ddf15d72e6ffd8d7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/101891fe7b623537c275f8e67767356b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
08608527c792df28
Type
Standard
Back to TGA Approvals
MALARONE TABLETS (250/100) atovaquone and proguanil hydrochloride tablet blister pack - TGA Drug Approval Details